All companies
Visit website
RYCA INTERNATIONAL
OperatingRyca International, Inc.
Healthcare · Founded 2007
Effortless Oral Care
Post-money valuation ⓘ
$28.2M
As of Sep 2024 · from Ryca International Common Stock 2 · pre-money + amount raised, not a traded price
Total raised
$1,544,096
Across 3 rounds since 2020
Latest share price
$3.50
Ryca International Common Stock 2 offering price
Financials
FY2018–FY2023 · from SEC filings · hover any figure for its source$0
2018
$0
−$250K
2019
$0
−$606K
2020
$0
−$2.2M
2022
$0
−$2.5M
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2018
FY2019
FY2020
FY2022
FY2023
Income statement
Revenue
$0
$0
$0
$0
$0
Cost of goods sold
$0
$0
$0
$0
$0
Net income
$0
-$250,494
-$606,020
-$2,170,427
-$2,535,687
Taxes paid
$0
$0
$0
$0
$0
Balance sheet
Cash
$0
$250,325
$413,177
$1,990,337
$429,108
Accounts receivable
$0
$0
$0
$0
$0
Total assets
$0
$250,325
$413,177
$2,004,266
$449,452
Short-term debt
$0
$378,219
$426,264
$0
$0
Long-term debt
$228,899
$326,399
$1,056,376
$6,821,139
$6,378,796
Total liabilities
$228,899
$1,096,612
$1,482,640
$6,821,139
$6,378,796
Other
Headcount
—
6
15
—
3
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$8.0M
Valuation cap
$28.2M
post-money
Ryca International, Inc. Convertible Note 1
Ryca International Common Stock 2
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $474.1K / $618KInvestors 95Post-money $28.2M
Raised $0
Raised / $1.1M
Reg CF annual-report compliance
Not requiredFiled Form C-TR (terminated reporting)
Filed 0 of 6 annual reports (FY2020–FY2025)
1,965 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 9 filings on EDGARSource: ManualCIK 0001810373Share price $3.50
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.